Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Cancer Tissue Diagnostics Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 Immunohistochemistry (IHC) Test
  • 1.4.3 In Situ Hybridisation Test
• 1.5 Market by Application
  • 1.5.1 Global Cancer Tissue Diagnostics Market Share by Application (2019-2025)
  • 1.5.2 Hospitals
  • 1.5.3 Clinics
  • 1.5.4 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Cancer Tissue Diagnostics Market Size
• 2.2 Cancer Tissue Diagnostics Growth Trends by Regions
  • 2.2.1 Cancer Tissue Diagnostics Market Size by Regions (2019-2025)
  • 2.2.2 Cancer Tissue Diagnostics Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players

• 3.1 Cancer Tissue Diagnostics Market Size by by Players
  • 3.1.1 Global Cancer Tissue Diagnostics Revenue by by Players (2014-2019)
  • 3.1.2 Global Cancer Tissue Diagnostics Revenue Market Share by by Players (2014-2019)
  • 3.1.3 Global Cancer Tissue Diagnostics Market Concentration Ratio (CR5 and HHI)
• 3.2 Cancer Tissue Diagnostics Key Players Head office and Area Served
• 3.3 Key Players Cancer Tissue Diagnostics Product/Solution/Service
• 3.4 Date of Enter into Cancer Tissue Diagnostics Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Cancer Tissue Diagnostics Market Size by Type (2014-2019)
• 4.2 Global Cancer Tissue Diagnostics Market Size by Application (2014-2019)

5 North America

• 5.1 North America Cancer Tissue Diagnostics Market Size (2014-2019)
• 5.2 Cancer Tissue Diagnostics Key Players in North America
• 5.3 North America Cancer Tissue Diagnostics Market Size by Type
• 5.4 North America Cancer Tissue Diagnostics Market Size by Application

6 Europe

• 6.1 Europe Cancer Tissue Diagnostics Market Size (2014-2019)
• 6.2 Cancer Tissue Diagnostics Key Players in Europe
• 6.3 Europe Cancer Tissue Diagnostics Market Size by Type
• 6.4 Europe Cancer Tissue Diagnostics Market Size by Application

7 China

• 7.1 China Cancer Tissue Diagnostics Market Size (2014-2019)
• 7.2 Cancer Tissue Diagnostics Key Players in China
• 7.3 China Cancer Tissue Diagnostics Market Size by Type
• 7.4 China Cancer Tissue Diagnostics Market Size by Application

8 Japan

• 8.1 Japan Cancer Tissue Diagnostics Market Size (2014-2019)
• 8.2 Cancer Tissue Diagnostics Key Players in Japan
• 8.3 Japan Cancer Tissue Diagnostics Market Size by Type
• 8.4 Japan Cancer Tissue Diagnostics Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Cancer Tissue Diagnostics Market Size (2014-2019)
• 9.2 Cancer Tissue Diagnostics Key Players in Southeast Asia
• 9.3 Southeast Asia Cancer Tissue Diagnostics Market Size by Type
• 9.4 Southeast Asia Cancer Tissue Diagnostics Market Size by Application

10 India

• 10.1 India Cancer Tissue Diagnostics Market Size (2014-2019)
• 10.2 Cancer Tissue Diagnostics Key Players in India
• 10.3 India Cancer Tissue Diagnostics Market Size by Type
• 10.4 India Cancer Tissue Diagnostics Market Size by Application

11 Central & South America

• 11.1 Central & South America Cancer Tissue Diagnostics Market Size (2014-2019)
• 11.2 Cancer Tissue Diagnostics Key Players in Central & South America
• 11.3 Central & South America Cancer Tissue Diagnostics Market Size by Type
• 11.4 Central & South America Cancer Tissue Diagnostics Market Size by Application

12 International Players Profiles

• 12.1 F. Hoffmann-La Roche Ltd.
  • 12.1.1 F. Hoffmann-La Roche Ltd. Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Cancer Tissue Diagnostics Introduction
  • 12.1.4 F. Hoffmann-La Roche Ltd. Revenue in Cancer Tissue Diagnostics Business (2014-2019))
  • 12.1.5 F. Hoffmann-La Roche Ltd. Recent Development
• 12.2 Danaher Corporation
  • 12.2.1 Danaher Corporation Company Details
  • 12.2.2 Company Description and Business Overview
  • 12.2.3 Cancer Tissue Diagnostics Introduction
  • 12.2.4 Danaher Corporation Revenue in Cancer Tissue Diagnostics Business (2014-2019)
  • 12.2.5 Danaher Corporation Recent Development
• 12.3 Thermo Fisher Scientific Inc.
  • 12.3.1 Thermo Fisher Scientific Inc. Company Details
  • 12.3.2 Company Description and Business Overview
  • 12.3.3 Cancer Tissue Diagnostics Introduction
  • 12.3.4 Thermo Fisher Scientific Inc. Revenue in Cancer Tissue Diagnostics Business (2014-2019)
  • 12.3.5 Thermo Fisher Scientific Inc. Recent Development
• 12.4 Bio Rad Laboratories Inc.
  • 12.4.1 Bio Rad Laboratories Inc. Company Details
  • 12.4.2 Company Description and Business Overview
  • 12.4.3 Cancer Tissue Diagnostics Introduction
  • 12.4.4 Bio Rad Laboratories Inc. Revenue in Cancer Tissue Diagnostics Business (2014-2019)
  • 12.4.5 Bio Rad Laboratories Inc. Recent Development
• 12.5 Abbott
  • 12.5.1 Abbott Company Details
  • 12.5.2 Company Description and Business Overview
  • 12.5.3 Cancer Tissue Diagnostics Introduction
  • 12.5.4 Abbott Revenue in Cancer Tissue Diagnostics Business (2014-2019)
  • 12.5.5 Abbott Recent Development
• 12.6 Enzo Life Sciences, Inc.
  • 12.6.1 Enzo Life Sciences, Inc. Company Details
  • 12.6.2 Company Description and Business Overview
  • 12.6.3 Cancer Tissue Diagnostics Introduction
  • 12.6.4 Enzo Life Sciences, Inc. Revenue in Cancer Tissue Diagnostics Business (2014-2019)
  • 12.6.5 Enzo Life Sciences, Inc. Recent Development
• 12.7 Agilent Technologies, Inc.
  • 12.7.1 Agilent Technologies, Inc. Company Details
  • 12.7.2 Company Description and Business Overview
  • 12.7.3 Cancer Tissue Diagnostics Introduction
  • 12.7.4 Agilent Technologies, Inc. Revenue in Cancer Tissue Diagnostics Business (2014-2019)
  • 12.7.5 Agilent Technologies, Inc. Recent Development
• 12.8 Cancer Genetics Inc.
  • 12.8.1 Cancer Genetics Inc. Company Details
  • 12.8.2 Company Description and Business Overview
  • 12.8.3 Cancer Tissue Diagnostics Introduction
  • 12.8.4 Cancer Genetics Inc. Revenue in Cancer Tissue Diagnostics Business (2014-2019)
  • 12.8.5 Cancer Genetics Inc. Recent Development
• 12.9 Merck KGaA (Sigma-Aldrich Co. LLC)
  • 12.9.1 Merck KGaA (Sigma-Aldrich Co. LLC) Company Details
  • 12.9.2 Company Description and Business Overview
  • 12.9.3 Cancer Tissue Diagnostics Introduction
  • 12.9.4 Merck KGaA (Sigma-Aldrich Co. LLC) Revenue in Cancer Tissue Diagnostics Business (2014-2019)
  • 12.9.5 Merck KGaA (Sigma-Aldrich Co. LLC) Recent Development
• 12.10 Abcam plc.
  • 12.10.1 Abcam plc. Company Details
  • 12.10.2 Company Description and Business Overview
  • 12.10.3 Cancer Tissue Diagnostics Introduction
  • 12.10.4 Abcam plc. Revenue in Cancer Tissue Diagnostics Business (2014-2019)
  • 12.10.5 Abcam plc. Recent Development

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Product (2019-2025)
• 13.2 Market Size Forecast by Application (2019-2025)
• 13.3 Market Size Forecast by Regions
• 13.4 North America
• 13.5 Europe
• 13.6 China
• 13.7 Japan
• 13.8 Southeast Asia
• 13.9 India
• 13.10 Central & South America

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 15.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer

This report focuses on the global Cancer Tissue Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cancer Tissue Diagnostics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
F. Hoffmann-La Roche Ltd.
Danaher Corporation
Thermo Fisher Scientific Inc.
Bio Rad Laboratories Inc.
Abbott
Enzo Life Sciences, Inc.
Agilent Technologies, Inc.
Cancer Genetics Inc.
Merck KGaA (Sigma-Aldrich Co. LLC)
Abcam plc.

Market segment by Type, the product can be split into
Immunohistochemistry (IHC) Test
In Situ Hybridisation Test

Market segment by Application, split into
Hospitals
Clinics
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Cancer Tissue Diagnostics status, future forecast, growth opportunity, key market and key players.
To present the Cancer Tissue Diagnostics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Cancer Tissue Diagnostics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.